TTY Biopharm Company Limited (TPEX:4105)

TTY Biopharm Company Revenue

TTY Biopharm Company had revenue of 1.82B TWD in the quarter ending September 30, 2025, with 18.68% growth. This brings the company's revenue in the last twelve months to 6.50B, up 11.61% year-over-year. In the year 2024, TTY Biopharm Company had annual revenue of 5.89B with 7.05% growth.

• Revenue (ttm): 6.50B
• Revenue Growth: +11.61%
• P/S Ratio: 3.18
• Revenue / Employee: 19.01M
• Employees: 342
• Market Cap: 20.69B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.89B	388.31M	7.05%
Dec 31, 2023	5.51B	443.94M	8.77%
Dec 31, 2022	5.06B	526.00M	11.60%
Dec 31, 2021	4.54B	313.77M	7.43%
Dec 31, 2020	4.22B	-244.47M	-5.47%